NSC 15364
NSC 15364 is an inhibitor of VDAC1 oligomerization and apoptosis[1].
Product Specifications
CAS Number
[4550-72-5]
UNSPSC
12352005
Hazard Statement
H314
Target
Apoptosis; VDAC
Type
Reference compound
Related Pathways
Apoptosis; Membrane Transporter/Ion Channel
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/nsc-15364.html
Purity
99.67
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=C(N)C=C1)NC2=CC=C(N)C=C2
Molecular Formula
C13H14N4O
Molecular Weight
242.28
Precautions
H314
References & Citations
[1]Ben-Hail D, et al. Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction. J Biol Chem. 2016 Nov 25;291 (48) :24986-25003.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
VDAC1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1292797-01 0.02 mg (E-Coli)
Recombinant Human Putative uncharacterized protein encoded by LINC00114 (LINC00114)
Ask
View Details 
MBS1292797-02 0.1 mg (E-Coli)
Recombinant Human Putative uncharacterized protein encoded by LINC00114 (LINC00114)
Ask
View Details 
MBS1292797-03 0.02 mg (Yeast)
Recombinant Human Putative uncharacterized protein encoded by LINC00114 (LINC00114)
Ask
View Details MBS1292797-04 0.1 mg (Yeast)
Recombinant Human Putative uncharacterized protein encoded by LINC00114 (LINC00114)
Ask
View Details MBS1292797-05 0.02 mg (Baculovirus)
Recombinant Human Putative uncharacterized protein encoded by LINC00114 (LINC00114)
Ask
View Details 
MBS1292797-06 0.02 mg (Mammalian-Cell)
Recombinant Human Putative uncharacterized protein encoded by LINC00114 (LINC00114)
Ask
View Details